Healthy high growth potential

Results

1547

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1547 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
TMGH
ج.م97.70-0.1%77.6%ج.م201.3bج.م141.9013.035.9%0.3%Real Estate Management and Development
FWRY
ج.م19.211.1%41.4%ج.م65.4bج.م22.4524.627.3%n/aDiversified Financials
SAUD3
R$13.800.2%6.2%R$40.3bR$17.6938.331.9%5.9%Healthcare
AXSM
US$208.03-2.6%75.5%US$10.9bUS$285.4214.061.1%n/aPharmaceuticals & Biotech
601567
CN¥14.84-2.9%-36.6%CN¥20.8bCN¥35.7721.845.6%4.2%Capital Goods
2315
HK$65.00-5.8%160.0%HK$59.8bHK$62.0385.841.0%n/aPharmaceuticals & Biotech
AV1
AU$0.066-5.7%-60.0%AU$61.2mAU$0.166.4107.8%n/aSoftware
3036
NT$206.00-1.9%68.2%NT$261.7bNT$314.8610.728.9%3.8%Tech
A458870
₩20,900.00-12.7%42.2%₩795.4b₩62,666.6726.139.7%n/aHealthcare
688700
CN¥57.45-0.6%25.5%CN¥17.1bCN¥61.6796.561.7%0.6%Capital Goods
5038
JP¥2,256.00-2.0%-20.6%JP¥34.1bJP¥2,270.0028.320.3%0.9%Healthcare
2480
HK$13.100%-47.6%HK$2.6bHK$31.003.477.1%n/aPharmaceuticals & Biotech
002975
CN¥100.550.6%179.1%CN¥20.9bCN¥130.0089.944.2%0%Tech
2171
HK$13.53-9.9%-35.8%HK$8.0bHK$18.3350.5131.5%n/aPharmaceuticals & Biotech
2455
NT$406.007.0%184.9%NT$75.1bNT$400.0098.444.7%0.7%Semiconductors
6223
NT$5,465.00-15.1%363.1%NT$535.5bNT$8,581.54116.961.5%0.4%Semiconductors
300432
CN¥15.98-1.5%3.0%CN¥27.3bCN¥34.4053.960.7%0.6%Automobiles
3277
HK$71.80-2.0%n/aHK$32.0bHK$115.3593.234.2%0.4%Tech
002384
CN¥201.08-2.0%277.5%CN¥366.5bCN¥188.00179.773.1%0%Tech
NORTHERN
RM 0.690%-7.4%RM 271.0mRM 1.0017.739.5%n/aCapital Goods
501423
₹3,321.90-1.4%57.6%₹152.8b₹3,916.6786.437.3%0.09%Capital Goods
002970
CN¥50.46-3.6%0.9%CN¥9.2bn/a28.236.5%2.0%Automobiles
509496
₹1,274.65-1.9%67.0%₹219.0b₹1,579.7536.428.9%0.2%Capital Goods
600183
CN¥132.80-7.3%178.9%CN¥322.6bCN¥168.9562.129.4%1.2%Tech
Page 1 of 43